Advances in microbicide vaginal rings.
暂无分享,去创建一个
Thomas J. Smith | Patrick Kiser | Thomas J Smith | R. Malcolm | J. Romano | P. Kiser | R Karl Malcolm | Karen-Leigh Edwards | Joseph Romano | K. Edwards | R. Malcolm
[1] A. T. N. Group,et al. Local Treatment of Urogenital Atrophy with an Estradiol-Releasing Vaginal Ring: A Comparative and a Placebo-Controlled Multicenter Study , 1999, International Urogynecology Journal.
[2] H. Rees,et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial , 2002, The Lancet.
[3] C. Lacey,et al. Microbicides and HIV prevention: lessons from the past, looking to the future , 2010, Current opinion in infectious diseases.
[4] M. Krumme,et al. Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. , 2010, Antiviral research.
[5] Patrick A Tresco,et al. Polyurethane intravaginal ring for controlled delivery of dapivirine, a nonnucleoside reverse transcriptase inhibitor of HIV-1. , 2008, Journal of pharmaceutical sciences.
[6] Shayne C. Gad,et al. Pharmaceutical manufacturing handbook : production and processes , 2008 .
[7] C. Westhoff,et al. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. , 2006, Contraception.
[8] M Szycher,et al. Biostability of Polyurethane Elastomers: A Critical Review , 1988, Journal of biomaterials applications.
[9] L. Cardozo,et al. A new intravaginal device for stress incontinence in women , 2001, BJU international.
[10] Patrick F. Kiser,et al. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[11] C. Mauck,et al. SILCS Diaphragm: Postcoital Testing of a New Single-Size Contraceptive Diaphragm* , 2006 .
[12] A. Woolfson,et al. Design of a silicone reservoir intravaginal ring for the delivery of oxybutynin. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[13] John P. Moore,et al. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission. , 2008, Annual review of medicine.
[14] D. Apter,et al. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. , 2001, Human reproduction.
[15] Jerome H. Kim,et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. , 2009, The New England journal of medicine.
[16] K. Barnhart,et al. In vivo assessment of NuvaRing placement. , 2005, Contraception.
[17] David R. Holtgrave,et al. Using cost-effectiveness league tables to compare interventions to prevent sexual transmission of HIV. , 2001, AIDS.
[18] J. H. van de Wijgert,et al. Challenges in microbicide trial design and implementation. , 2006, Studies in family planning.
[19] H. Vromans,et al. In vitro release properties of etonogestrel and ethinyl estradiol from a contraceptive vaginal ring. , 2002, International journal of pharmaceutics.
[20] Mukul Singh,et al. Sustained release of microbicides by newly engineered vaginal rings , 2009, AIDS.
[21] Claire C. Yang,et al. Magnetic resonance imaging of SILCS diaphragm: anatomical considerations and corroboration with clinical fit. , 2007, Contraception.
[22] M. H. Sousa,et al. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences. , 2007, Contraception.
[23] F. Roumen,et al. Clinical acceptability of an ethylene-vinyl-acetate nonmedicated vaginal ring. , 1999, Contraception.
[24] P. Dziuk,et al. Passage of steroids through silicone rubber. , 1966, Endocrinology.
[25] A. Rajabi-Siahboomi,et al. Aqueous film coating to reduce recrystallization of guaifenesin from hot-melt extruded acrylic matrices , 2010, Drug development and industrial pharmacy.
[26] D. Taylor-Robinson,et al. Safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[27] G. Doncel,et al. Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers. , 2010, Antiviral research.
[28] Qi Wang,et al. Properties, and Applications , 2005 .
[29] J. Vartiainen,et al. Effects and acceptability of a new 17 beta-oestradiol-releasing vaginal ring in the treatment of postmenopausal complaints. , 1993, Maturitas.
[30] B. Friedland,et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.
[31] A. Woolfson,et al. Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. , 2005, The Journal of antimicrobial chemotherapy.
[32] A. Woolfson,et al. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. , 2006, International journal of pharmaceutics.
[33] U. Karck,et al. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, NuvaRing®: Results of clinical experience in Germany , 2008, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[34] Robin Shattock,et al. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. , 2010, Antiviral research.
[35] A. Woolfson,et al. Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non‐human primates , 2009, Journal of medical primatology.
[36] L. Nachtigall. Clinical trial of the estradiol vaginal ring in the U.S. , 1995, Maturitas.
[37] H. Sangi-Haghpeykar,et al. Safety and acceptability with the use of a contraceptive vaginal ring after surgical or medical abortion. , 2007, Contraception.
[38] T. Foran. New contraceptive choices across reproductive life , 2003, The Medical journal of Australia.
[39] P. V. D. van de Weijer,et al. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. , 1997, European journal of obstetrics, gynecology, and reproductive biology.
[40] James W McGinity,et al. The influence of heterogeneous nucleation on the surface crystallization of guaifenesin from melt extrudates containing Eudragit L10055 or Acryl-EZE. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[41] K. Malcolm. Vaginal rings for controlled-release drug delivery , 2008 .
[42] Michael A Repka,et al. Applications of hot-melt extrusion for drug delivery , 2008, Expert opinion on drug delivery.
[43] J. Siepmann,et al. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). , 2001 .
[44] M. B. James,et al. Preparation of glass solutions of three poorly water soluble drugs by spray drying, melt extrusion and ball milling. , 2007, International journal of pharmaceutics.
[45] A. Woolfson,et al. Freeze-dried, mucoadhesive system for vaginal delivery of the HIV microbicide, dapivirine: optimisation by an artificial neural network. , 2010, International journal of pharmaceutics.
[46] D. Mishell,et al. Contraceptive effect of varying dosages of progestogen in silastic vaginal rings. , 1970, Fertility and sterility.
[47] A. Mashak,et al. Silicone Polymers in Controlled Drug Delivery Systems: A Review , 2009 .
[48] Charles E. Martin,et al. Pharmaceutical Applications of Hot-Melt Extrusion: Part I , 2007, Drug development and industrial pharmacy.
[49] C. Loge,et al. The combined contraceptive vaginal ring, NuvaRing: an international study of user acceptability. , 2003, Contraception.
[50] E. Fuchs,et al. Topical microbicides to prevent HIV: clinical drug development challenges. , 2009, Annual review of pharmacology and toxicology.
[52] D. Apter,et al. Efficacy, Cycle Control, and User Acceptability of a Novel Combined Contraceptive Vaginal Ring , 2002, Obstetrics and gynecology.
[53] A. Woolfson,et al. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy , 2007, The Journal of pharmacy and pharmacology.
[54] C. Reyes,et al. Acceptability of the contraceptive vaginal ring by rural and urban population in two Latin American countries. , 1981, Contraception.
[55] Clare F. McCoy,et al. Safety and Pharmacokinetics of Dapivirine Delivery From Matrix and Reservoir Intravaginal Rings to HIV-Negative Women , 2009, Journal of acquired immune deficiency syndromes.
[56] G. Doncel,et al. Preventing mucosal HIV transmission with topical microbicides: challenges and opportunities. , 2010, Antiviral research.
[57] C. Mauck,et al. SILCS diaphragm: postcoital testing of a new single-size contraceptive device. , 2008, Contraception.
[58] Mukul Singh,et al. Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents. , 2007, Contraception.
[59] C. Hendrix,et al. Clinical evaluation of microbicide formulations. , 2010, Antiviral research.
[60] D. Mishell,et al. Contraception by means of a silastic vaginal ring impregnated with medroxyprogesterone acetate. , 1970, American journal of obstetrics and gynecology.
[61] K. Malcolm,et al. In vitro release of nonoxynol-9 from silicone matrix intravaginal rings. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[62] D. Craig,et al. Influence of silicone elastomer solubility and diffusivity on the in vitro release of drugs from intravaginal rings. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[63] D. Mishell,et al. Progestin-only contraceptive rings , 2000, Steroids.
[64] M. Lederman,et al. Microbicides and other topical strategies to prevent vaginal transmission of HIV , 2006, Nature Reviews Immunology.
[65] S. Suissa,et al. A multinational evaluation of the efficacy, safety and acceptability of the Protectaid® contraceptive sponge , 2001, The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception.
[66] G. Doncel,et al. Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies. , 2010, Antiviral research.
[67] L. V. Van Bortel,et al. Safety and availability of dapivirine (TMC120) delivered from an intravaginal ring. , 2009, AIDS research and human retroviruses.
[68] David Grewell,et al. Welding of Plastics: Fundamentals and New Developments , 2007 .
[69] H. Vromans,et al. Effect of supersaturation and crystallization phenomena on the release properties of a controlled release device based on EVA copolymer. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[70] S. Kapiga,et al. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women , 2009, AIDS.
[71] Stephanie Q. Mistretta,et al. Adherence and Acceptability of the Contraceptive Ring Compared With the Pill Among Students: A Randomized Controlled Trial , 2010, Obstetrics and gynecology.